Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Queensland Health
US Department of Justice
Boehringer Ingelheim
Express Scripts
McKesson
Citi
Johnson and Johnson
Deloitte

Generated: July 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018658

« Back to Dashboard

NDA 018658 describes DELSYM, which is a drug marketed by Reckitt Benckiser and is included in one NDA. It is available from six suppliers. Additional details are available on the DELSYM profile page.

The generic ingredient in DELSYM is dextromethorphan polistirex. There are twenty-three drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the dextromethorphan polistirex profile page.
Summary for 018658
Tradename:DELSYM
Applicant:Reckitt Benckiser
Ingredient:dextromethorphan polistirex
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 018658
Suppliers and Packaging for NDA: 018658
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DELSYM dextromethorphan polistirex SUSPENSION, EXTENDED RELEASE;ORAL 018658 NDA Atlantic Biologicals Corps 17856-0276 N 17856-0276-1
DELSYM dextromethorphan polistirex SUSPENSION, EXTENDED RELEASE;ORAL 018658 NDA Rebel Distributors Corp 21695-517 E 21695-517-30

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:SUSPENSION, EXTENDED RELEASE;ORALStrengthEQ 30MG HBR/5ML
Approval Date:Oct 8, 1982TE:RLD:Yes

Expired US Patents for NDA 018658

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Reckitt Benckiser DELSYM dextromethorphan polistirex SUSPENSION, EXTENDED RELEASE;ORAL 018658-001 Oct 8, 1982 ➤ Sign Up ➤ Sign Up
Reckitt Benckiser DELSYM dextromethorphan polistirex SUSPENSION, EXTENDED RELEASE;ORAL 018658-001 Oct 8, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Daiichi Sankyo
QuintilesIMS
Cerilliant
Fish and Richardson
Deloitte
Mallinckrodt
Farmers Insurance
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.